News & Updates

Show Multimedia Only

Dark chocolates linked to lower T2D risk

19 Dec 2024 by

Eating dark chocolates may help reduce the risk of type 2 diabetes (T2D), whereas milk chocolates tend to promote long-term weight gain, as shown in a study.

Dark chocolates linked to lower T2D risk

19 Dec 2024

Tirzepatide reduces CV death, worsening HF in obese patients with HFpEF

18 Dec 2024 by

Treatment with tirzepatide reduced the risk of cardiovascular (CV) death and worsening heart failure (HF) in patients with HF with preserved ejection fraction (HFpEF) and obesity, according to the SUMMIT trial presented at AHA 2024.

Tirzepatide reduces CV death, worsening HF in obese patients with HFpEF

18 Dec 2024

Risk of myasthenia gravis onset highest in first month after statin initiation

14 Dec 2024 by

A study investigating the association between the risk of myasthenia gravis (MG) and statin therapy found the risk of onset in patients with no prior history of MG and the risk of exacerbation among patients with pre-existing MG were the highest in the first month after initiating statins.

Risk of myasthenia gravis onset highest in first month after statin initiation

14 Dec 2024

Diabetic retinopathy progression lower with empagliflozin vs DPP-4 inhibitor

13 Dec 2024 by

In patients with type 2 diabetes (T2D), treatment with empagliflozin has a null effect on the risk of nonproliferative diabetic retinopathy (NPDR) compared with a DPP-4 inhibitor but may confer protection against DR progression, according to a study.

Diabetic retinopathy progression lower with empagliflozin vs DPP-4 inhibitor

13 Dec 2024

Generic antiobesity drugs viable after successful weight loss with GLP-1 RA

12 Dec 2024 by

Older-generation generic antiobesity medications (AOMs) for weight maintenance may be prescribed to patients who have achieved successful weight loss with glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, suggests a study.

Generic antiobesity drugs viable after successful weight loss with GLP-1 RA

12 Dec 2024

Diet, exercise reduce serum lipids linked to insulin resistance

12 Dec 2024

Lifestyle interventions, including diet and exercise, can help lower serum sphingolipid species associated with insulin resistance, suggest the results of a recent study.

Diet, exercise reduce serum lipids linked to insulin resistance

12 Dec 2024

GLP1-RAs hold potential for asthma control

12 Dec 2024 by

Data presented at APSR 2024 demonstrate the ability of glucagon-like peptide 1 receptor agonists (GLP1-RAs) to benefit obese individuals with asthma.

GLP1-RAs hold potential for asthma control

12 Dec 2024

Pushing BP levels to lower targets better for cardioprotection in T2D

10 Dec 2024 by

Intensive systolic blood pressure (BP)-lowering treatment to reach target levels of less than 120 mm Hg is more beneficial than standard treatment in terms of reducing the risk of major cardiovascular events in Chinese patients with type 2 diabetes (T2D) and elevated BP, according to data from the BPROAD* trial.

Pushing BP levels to lower targets better for cardioprotection in T2D

10 Dec 2024

Nirmatrelvir-ritonavir efficacy and risk factors for COVID-19 hospitalization

10 Dec 2024

The post-pandemic burden of COVID-19 remains significant in adults. Four studies from IDWeek 2024 highlight the benefits of nirmatrelvir-ritonavir (NMV/r) for high-risk adults with SARS-CoV-2 immunity and link chronic conditions to COVID-19 hospitalization. Identifying high-risk patients and using NMV/r in outpatient settings can reduce severe outcomes.

Nirmatrelvir-ritonavir efficacy and risk factors for COVID-19 hospitalization

10 Dec 2024

Cardiometabolic risk factors mediate link between body composition, bone mineral content

08 Dec 2024

The number of cardiometabolic risk (CMR) factors plays an important role in mediating the association between fat percentage and bone mineral content (BMC) percentage in children, suggests a study.

Cardiometabolic risk factors mediate link between body composition, bone mineral content

08 Dec 2024

News & Updates

Filter by Specialty:

Specialty:

Dark chocolates linked to lower T2D risk

Dark chocolates linked to lower T2D risk

Tirzepatide reduces CV death, worsening HF in obese patients with HFpEF

Tirzepatide reduces CV death, worsening HF in obese patients with HFpEF

Risk of myasthenia gravis onset highest in first month after statin initiation

Risk of myasthenia gravis onset highest in first month after statin initiation

Diabetic retinopathy progression lower with empagliflozin vs DPP-4 inhibitor

Diabetic retinopathy progression lower with empagliflozin vs DPP-4 inhibitor

Generic antiobesity drugs viable after successful weight loss with GLP-1 RA

Generic antiobesity drugs viable after successful weight loss with GLP-1 RA

Diet, exercise reduce serum lipids linked to insulin resistance

Diet, exercise reduce serum lipids linked to insulin resistance

GLP1-RAs hold potential for asthma control

GLP1-RAs hold potential for asthma control

Pushing BP levels to lower targets better for cardioprotection in T2D

Pushing BP levels to lower targets better for cardioprotection in T2D

Nirmatrelvir-ritonavir efficacy and risk factors for COVID-19 hospitalization

Nirmatrelvir-ritonavir efficacy and risk factors for COVID-19 hospitalization

Cardiometabolic risk factors mediate link between body composition, bone mineral content

Cardiometabolic risk factors mediate link between body composition, bone mineral content